Epidemiology of Non-Hodgkin Lymphomas in the 20th and at the beginning of the 21st century
DOI:
https://doi.org/10.14739/2310-1237.2014.3.36544Keywords:
non-Hodgkin Lymphomas, Morbidity, Mortality, Risk FactorsAbstract
Aim: to study the dynamics of incidence, mortality, survival of patients with non-Hodgkin lymphomas in the world, Ukraine and Zaporizhzhya region in the 20th and at the beginning of the 21st century. The modern understanding of the etiology and prognostic factors of the disease was considered.Methods and results. In order to study the dynamics of incidence, mortality, survival of patients with non-Hodgkin lymphomas in the world, Ukraine, Zaporizhzhya region in the 20th and early 21st century the review of the specialized literature was conducted. We also considered the current ideas about etiology and risk factors of the disease. Non-Hodgkin lymphomas are complicated and poorly treatable diseases, which are found everywhere, and affect all age groups of people. The peak incidence occurs in the elderly and senile age. Continuing the study of non-Hodgkin lymphomas contributes to a better understanding of this disease, which leads to the reduction in mortality and increased survival of patients with non-Hodgkin lymphomas.
Conclusion. So, at the beginning of the 21st century, the non-Hodgkin lymphomas remain to be difficult to prevent, diagnose and treat malignant tumors, the incidence of which continues to increase.
References
Vud, M., & Bann, P. (1997). Sekrety gematologii i onkologii [Secrets of hematology and oncology]. Moscow: BINOM. [in Russian].
Karnabeda, O., Het`man, L., & Antonyak, S. (2013). VICH-associirovannye nehodzhkinskie limfomy [AIDS-associated non-Hodgkin's lymphoma]. Klinicheskaya onkologiya, 10(2), 108–115. [in Ukrainian].
Sivkovich, S., & Gubareva, A. (2006). Nehodzhkinskie limfomy [Non-Hodgkin's lymphoma]. Mystetstvo lLikuvannia, 027(1), 77–81. [in Ukrainian].
Smulevich, V., Solenova, L., & Belyakova, S. (1988). Zabolevaemost` i smertnost` ot zlokachestvennykh novoobrazovanij. Seriya; onkologiya [Morbidity and mortality from cancer. Series: Oncology]. Moscow: VINITI. [in Russian].
Tumanskij, V., & Shavrin, V. (2013). Mukozo-associirovannaya (MALT) limfoma zheludka: osobennosti patomorfologicheskoj diagnostiki [Mucositis-associated (MALT) lymphoma of the stomach: features Pathology Diagnostics]. Patologiya, 27(1), 85–89. [in Ukrainian].
Khanson, K., & Imyanitov, E. (2004). Epidemiologiya i biologiya nehodzhkinskih limfom [Epidemiology and biology of non-Hodgkin's lymphoma]. Prakticheskaya onkologiya, 5(3), 163–167. [in Russian].
Fedorenko, Z., Hulak, L., & Horokh, E. (2001). Biuleten natsionalnoho kantser-reiestru Ukrainy [Byuliten of the National Cancer Registry of Ukraine]. Rak v Ukraini, 1, 100–102. [in Ukrainian].
Fedorenko, Z., Hulak, L., & Horokh, E. (2004). Biuleten natsionalnoho kantser-reiestru Ukrainy [Byuliten of the National Cancer Registry of Ukraine]. Rak v Ukraini, 5, 55–57. [in Ukrainian].
Fedorenko, Z., Hulak, L., & Horokh, E. (2013). Biuleten natsionalnoho kantser-reiestru Ukrainy. [Byuliten of the National Cancer Registry of Ukraine]. Rak v Ukraini, 14, 66–67. [in Ukrainian].
(1994). A clinical evaluation of the International Lymphoma. Study Group classification of non-Hodgkin’s lymphoma. The non-Hodgkin Lymphoma Classification Project. Blood, 89, 3909–3918.
Beral, V., Peterman, T., Berkelman, R., & Jaffe, H. (1991). AIDS, associated non-Hodgkin lymphoma. Lancet, 338, 884–885.
Clarke, C., & Glaser, S. (2014). Changing incidence of non-Hodgkin lymphomas of US. Cancer, 94, 2015–2023.
Garcia, M., Jemal, A., Ward, E., & Center, M. (2007). Global Cancer Facts & Figures. Atlanta.
Harris, N., Stein, H., & Coupland, S. (2001). New approaches to lymphoma diagnosis. Hematology, 1, 194–220.
Jaffe, E., Harris, N., & Stein, H. (2014). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press.
Jemal, A., Siegel, R., & Ward, R. (2008). Global Cancer Statistics 2008. CA Cancer J Clin, 58, 71–96.
Parkin, M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global Cancer Statistics, 2002. CA Cancer J Clin, 55, 74–108.
Rosenvald, A., Wright, G., & Cfan, W. (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New.Engl.J.Med, 364, 1937–1947.
Swerdlow, A., Barber, J., & Hudson, G. (2000). Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. Clinical Oncolgi, 18, 498–509.
Swerdlow, S., Campo, E., & Harris, N. (2008). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARS.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
